From September 21, 2022 to September 30, 2022, the company has repurchased 660,400 shares, representing 0.06% for CNY 19.99 million. With this, the company has completed the repurchase of 660,400 shares, representing 0.06% for CNY 19.99 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.44 CNY | -0.06% | -4.44% | -35.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.76% | 2.69B | |
+0.82% | 91.94B | |
-3.16% | 38.74B | |
+64.83% | 26.66B | |
-13.98% | 15.32B | |
-5.40% | 13.3B | |
-11.38% | 11.65B | |
+156.85% | 10.37B | |
-49.84% | 10.12B | |
+2.32% | 9.06B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.